Efficacy and Safety of Mirogabalin (DS-5565) for the Treatment of Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled, Adaptive Proof-of-Concept Phase 2 Study Article

authors

publication date

  • December 1, 2014

webpage

published in

start page

  • 3253

end page

  • 3261

volume

  • 37

issue

  • 12